60 DEGREES PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Diluted Shares Outstanding (Weighted Average) of 2.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 2.65M shares, a 620.66% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.73M shares, a 437.80% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 1.21M shares.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 3.68M shares, a 70.74% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 670.21K shares, a 489.64% increase from fiscal 2024.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 113.67K shares, a 71.40% increase from fiscal 2023.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 66.31K shares, a 97.20% decline from fiscal 2022.
- 60 DEGREES PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 2.37M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.65M shares 10-Q · filed 2026-08-14 | 2.19M shares 10-Q · filed 2026-08-14 | 1.86M shares derived: average of 3 quarters · filed 2026-08-14 | 2.32M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 1.73M shares 10-Q · filed 2026-05-15 | 1.47M shares derived: average of 2 quarters · filed 2026-05-15 | 2.21M shares derived: average of 3 quarters · filed 2026-05-15 | 1.75M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 1.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 2.45M shares derived: average of 2 quarters · filed 2026-03-30 | 1.75M shares derived: average of 3 quarters · filed 2026-08-14 | 670.21K shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 3.68M shares 10-Q · filed 2025-11-13 | 2.02M shares derived: average of 2 quarters · filed 2026-08-14 | 488.65K shares 10-Q · filed 2025-11-13 | 989.15K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 368.25K shares 10-Q · filed 2026-08-14 | 1.47M shares 10-Q · filed 2025-08-13 | 344.70K shares 10-Q · filed 2026-08-14 | 1.38M shares 10-Q · filed 2025-08-13 | 93.74K shares derived: average of 3 quarters · filed 2026-08-14 | 608.47K shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 320.89K shares 10-Q · filed 2026-05-15 | 1.28M shares 10-Q · filed 2025-05-15 | -43.52K shares derived: average of 2 quarters · filed 2026-05-15 | 688.55K shares derived: average of 3 quarters · filed 2026-05-15 | 567.15K shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -407.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 872.38K shares derived: average of 2 quarters · filed 2026-03-30 | 649.24K shares derived: average of 3 quarters · filed 2026-03-30 | 113.67K shares 10-K · filed 2026-03-30 | 454.58K shares 10-K · filed 2025-03-27 | |||
| 2024-09-30 | 2.15M shares 10-Q · filed 2025-11-13 | 2.44M shares 10-Q · filed 2024-11-14 | 1.18M shares derived: average of 2 quarters · filed 2025-11-13 | 287.53K shares 10-Q · filed 2025-11-13 | 1.44M shares 10-Q · filed 2024-11-14 | 487.12K shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 202.97K shares 10-Q · filed 2025-08-13 | 1.01M shares 10-Q · filed 2024-08-14 | 185.86K shares 10-Q · filed 2025-08-13 | 929.25K shares 10-Q · filed 2024-08-14 | -68.06K shares derived: average of 3 quarters · filed 2025-08-13 | 60.99K shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 168.76K shares 10-Q · filed 2025-05-15 | 10.12M shares 10-Q · filed 2024-05-15 | -203.58K shares derived: average of 2 quarters · filed 2025-05-15 | 13.67K shares derived: average of 3 quarters · filed 2025-05-15 | 59.80K shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -575.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -63.87K shares derived: average of 2 quarters · filed 2025-03-27 | 23.48K shares derived: average of 3 quarters · filed 2025-03-27 | 66.31K shares 10-K · filed 2025-03-27 | 3.96M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 448.17K shares 10-Q · filed 2024-11-14 | 5.32M shares 10-Q · filed 2023-11-20 | 323.17K shares derived: average of 2 quarters · filed 2024-11-14 | 280.39K shares 10-Q · filed 2024-11-14 | 3.34M shares 10-Q · filed 2023-11-20 | 1.33M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 198.17K shares 10-Q · filed 2024-08-14 | 2.38M shares 10-Q · filed 2023-08-25 | 195.11K shares 10-Q · filed 2024-08-14 | 2.34M shares 10-Q · filed 2023-08-25 | 1.63M shares derived: average of 3 quarters · filed 2024-08-14 | 1.82M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 2.30M shares 10-Q · filed 2024-05-15 | 2.35M shares derived: average of 2 quarters · filed 2024-05-15 | 2.36M shares derived: average of 3 quarters · filed 2024-05-15 | 2.36M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 2.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 2.39M shares derived: average of 2 quarters · filed 2024-04-01 | 2.37M shares derived: average of 3 quarters · filed 2024-04-01 | 2.37M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 2.39M shares 10-Q · filed 2023-11-20 | 2.37M shares derived: average of 2 quarters · filed 2023-11-20 | 2.36M shares 10-Q · filed 2023-11-20 | |||||
| 2022-06-30 | 2.35M shares 10-Q · filed 2023-08-25 | 2.35M shares 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |